日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Altered Expression of Growth Associated Protein-43 and Rho Kinase in Human Patients with Parkinson's Disease

帕金森病患者生长相关蛋白-43和Rho激酶表达改变

Saal, Kim-Ann; Galter, Dagmar; Roeber, Sigrun; Bähr, Mathias; Tönges, Lars; Lingor, Paul

Transcriptomic profiling of the human brain reveals that altered synaptic gene expression is associated with chronological aging

人脑转录组分析表明,突触基因表达的改变与生理衰老有关。

Dillman, Allissa A; Majounie, Elisa; Ding, Jinhui; Gibbs, J Raphael; Hernandez, Dena; Arepalli, Sampath; Traynor, Bryan J; Singleton, Andrew B; Galter, Dagmar; Cookson, Mark R

Strong association between glucocerebrosidase mutations and Parkinson's disease in Sweden

瑞典的葡萄糖脑苷脂酶基因突变与帕金森病之间存在密切关联

Ran, Caroline; Brodin, Lovisa; Forsgren, Lars; Westerlund, Marie; Ramezani, Mehrafarin; Gellhaar, Sandra; Xiang, Fengqing; Fardell, Camilla; Nissbrandt, Hans; Söderkvist, Peter; Puschmann, Andreas; Ygland, Emil; Olson, Lars; Willows, Thomas; Johansson, Anders; Sydow, Olof; Wirdefeldt, Karin; Galter, Dagmar; Svenningsson, Per; Belin, Andrea Carmine

ADAR2 affects mRNA coding sequence edits with only modest effects on gene expression or splicing in vivo

ADAR2 会影响 mRNA 编码序列的编辑,但对体内基因表达或剪接的影响甚微。

Dillman, Allissa A; Cookson, Mark R; Galter, Dagmar

No dopamine cell loss or changes in cytoskeleton function in transgenic mice expressing physiological levels of wild type or G2019S mutant LRRK2 and in human fibroblasts.

在表达生理水平的野生型或 G2019S 突变型 LRRK2 的转基因小鼠和人类成纤维细胞中,未观察到多巴胺细胞丢失或细胞骨架功能改变

Garcia-Miralles Marta, Coomaraswamy Janaky, Häbig Karina, Herzig Martin C, Funk Natalja, Gillardon Frank, Maisel Martina, Jucker Mathias, Gasser Thomas, Galter Dagmar, Biskup Saskia

mRNA expression, splicing and editing in the embryonic and adult mouse cerebral cortex

小鼠胚胎和成年大脑皮层中的mRNA表达、剪接和编辑

Dillman, Allissa A; Hauser, David N; Gibbs, J Raphael; Nalls, Michael A; McCoy, Melissa K; Rudenko, Iakov N; Galter, Dagmar; Cookson, Mark R

Modulation of the endoplasmic reticulum-mitochondria interface in Alzheimer's disease and related models

阿尔茨海默病及相关模型中内质网-线粒体界面调控

Hedskog, Louise; Pinho, Catarina Moreira; Filadi, Riccardo; Rönnbäck, Annica; Hertwig, Laura; Wiehager, Birgitta; Larssen, Pia; Gellhaar, Sandra; Sandebring, Anna; Westerlund, Marie; Graff, Caroline; Winblad, Bengt; Galter, Dagmar; Behbahani, Homira; Pizzo, Paola; Glaser, Elzbieta; Ankarcrona, Maria

Neurodegenerative phenotypes in an A53T α-synuclein transgenic mouse model are independent of LRRK2

A53T α-突触核蛋白转基因小鼠模型中的神经退行性表型与LRRK2无关。

Daher, João Paulo L; Pletnikova, Olga; Biskup, Saskia; Musso, Alessandra; Gellhaar, Sandra; Galter, Dagmar; Troncoso, Juan C; Lee, Michael K; Dawson, Ted M; Dawson, Valina L; Moore, Darren J

Genetic Screening of the Mitochondrial Rho GTPases MIRO1 and MIRO2 in Parkinson's Disease

帕金森病线粒体Rho GTP酶MIRO1和MIRO2的基因筛查

Anvret, Anna; Ran, Caroline; Westerlund, Marie; Sydow, Olof; Willows, Thomas; Olson, Lars; Galter, Dagmar; Belin, Andrea Carmine

Impaired nigrostriatal function precedes behavioral deficits in a genetic mitochondrial model of Parkinson's disease

在帕金森病的线粒体遗传模型中,黑质纹状体功能障碍先于行为缺陷出现。

Good, Cameron H; Hoffman, Alexander F; Hoffer, Barry J; Chefer, Vladimir I; Shippenberg, Toni S; Bäckman, Cristina M; Larsson, Nils-Göran; Olson, Lars; Gellhaar, Sandra; Galter, Dagmar; Lupica, Carl R